Clip
The Limitations of Blood Testing in Healthcare Tech
11:53 - 17:47 (05:53)
While certain molecules and blood components can be accurately measured with a small droplet of blood using sophisticated machines, the technology to replace comprehensive blood panels used in routine check-ups is not yet within reach.
Similar Clips
The intersection between venture capital and science can result in the over-inflation and downfall of companies.
1:15:28 - 1:17:05 (01:36)
Summary
The intersection between venture capital and science can result in the over-inflation and downfall of companies. The history of Genentech's incubation and sudden discovery of synthetic insulin is an example of this pattern.
ChapterThe Challenges of Industrial Synthetic Biology
EpisodeE89: GDP growth negative in Q2, $SHOP layoffs, Alzheimer's fraud, Ginkgo acquires Zymergen & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The CEO of Quest Diagnostics, Steve Rusckowski, discusses his company's journey from zero to 40 million dollars in sales in just three years and the challenge of creating a mix of one-time purchases, repeat business, and recurring contracts.
43:42 - 44:49 (01:07)
Summary
The CEO of Quest Diagnostics, Steve Rusckowski, discusses his company's journey from zero to 40 million dollars in sales in just three years and the challenge of creating a mix of one-time purchases, repeat business, and recurring contracts.
ChapterConsumer-Initiated Testing with Humana
Episode#51 - Coronavirus, Being on Shark Tank & At-Home Testing Kits with Julia Cheek
PodcastMy First Million
The infrastructure solutions that are urgently needed will not be funded by SoftBank but there's now a growing free market appetite for them as seen in the ballooning entrepreneurship, advancing technology, and pouring capital.
34:29 - 35:57 (01:28)
Summary
The infrastructure solutions that are urgently needed will not be funded by SoftBank but there's now a growing free market appetite for them as seen in the ballooning entrepreneurship, advancing technology, and pouring capital. These solutions are important for us to accelerate the outcome and emerge victorious in the war.
ChapterThe Impact of Illumina's Gene Sequencing Patents Expiry
EpisodeE46: False Ivermectin narratives, regulatory grift, wartime mentality in solving issues & more | LIVE from TPB Symposium!
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The speaker discusses how even if a thousand investments fail, hitting one hundred billion dollar company can make up for the losses and mentions potentially successful companies like Air Table, RAPI, Substack, and Clubhouse.
52:54 - 53:43 (00:48)
Summary
The speaker discusses how even if a thousand investments fail, hitting one hundred billion dollar company can make up for the losses and mentions potentially successful companies like Air Table, RAPI, Substack, and Clubhouse.
ChapterSeed Stage Investor's Perspective on Diversification
Episode#149 - The Craziness of r/WallStreetBets, an $100k Bet, and Startup Ideas with Mercury Banks Founder
PodcastMy First Million
The concept of radical transparency in healthcare can disrupt the industry as it helps in understanding pricing which is a major issue among patients and stakeholders.
18:13 - 19:59 (01:45)
Summary
The concept of radical transparency in healthcare can disrupt the industry as it helps in understanding pricing which is a major issue among patients and stakeholders. This could also be applicable in many other industries where trust is becoming an issue.